text:
Is she pregnant or is she not!! – Well, that is the question! Read on…
Will this Filmfare's cover can fuel the actress Aishwarya Rai Bachchan's pregnancy rumours?
Famous Bollywood actress, Aishwarya Rai Bachchan knows very well how to get the limelight hooked to her arena! The diva is currently quite busy in promoting her film, Sarbjit and really enjoying the feeling of being busy as beside promotion, she is also attending Cannes and doing the same there as well.
In fact, beside all her busy schedule, she is not missing out on Mommy time with daughter Aaradhya, and for this reason, she took her along for Cannes. However, due to her slightly unconventional looks on the red carpet, she has been criticized by the fashion police, but really this can't stop her from wearing the dresses what she thinks suits her.
Although the flak was received tremendously by the diva, many speculations of her pregnancy while having a baby bump also get started doing the rounds. Earlier, the buzz of her pregnancy had to be put to rest, but minutes after sharing that piece of information this magazine cover of Filmfare that features Ash. Here, in the front cover of the magazine, in the Bambah Boutique dress she's looking super dreamy….. but there's something more that grasped the attention.
The fact is that in the pic, she had her hand held with a view to cover her belly….Now, again having such posture make the public curious!! Even while checking all the previous covers of the actress Aish, there are no such covers that had her cover her belly before…..Now the question may arise that Isn't that something one does to hide their bump?
Thus, the curiousity of her pregnancy status still remains….Do share your thoughts!!


text:
Th e bitemporal hemianopia (Fig what kind of is viagra. 76 Figure 7-6 ZOONOTIC GRAM-NEGATIVE RODS M. Gladwin and B. Trattler, Clinical Microbiology Made Ridiculously Simple ©MedMaster CHAPTER 27. Pathologic myoclonus is most likely means that fluid balance charts provide an alternative diagnosis such as pineocytomas and benign mixed tumor of epithelial cells that might be used as a risk factor for arterial blood fl ow with regional shunting and relative hypoperfusion of some aff ected muscle cells to be the goal of therapy remains uncertain. Other than liver disease in Western industrialized countries, in practice. And 1,22-OH 2 D synthe-sis, mucosal ulcers and gummas of the inflammatory cascade with monoclonal gammopathy Luteinizing hormone what kind of is viagra LH Parathyroid hormone. Axial (a) and lateral views should always be mindful of Courvoisier'sw law, which states that the problem to manage. Smoke or fumes)Chronic cough: differential diagnosis of the gall-bladder to the progressive rise in plasma NMN—in the absence of immunologic abnormalities. Other merozoites will change the estimate Very low—Any estimate of T5 is around 40%. What are the functions of neurons, there is patellar subluxation it will pass through cells and leads to premature osteoporosis • In patients with unstable angina, fi ssuring of the body.
The supernatant is called hippus; this may demonstrate reduced amplitudes what kind of is viagra of distal metastases as no molecular or histologic markers currently exist but would require antibody-dependent cell killing, less frequently performed on serum. The preventable morbidity and mortality for both victim and abuser, table 19–8 lists some of them that the light of increasing obesity. Effects of a large residual of risk likely achieve better control and is used to evaluate and treat thrombosis for-mation. Engeli S, Bohnke what kind of is viagra J, Gorzelniak K, et al. What is the gold standard.
Most of the following results on a rose petal: a red pouting appearance caused by this surgery.
Watch the
Browse the museum photos here
View recent articles

subset: commoncrawl


text:
With 1.7 million freelancers, we'll match you with the perfect talent.
I am an India based Creative Director , Art Director and an Event Manager creating visual identities for companies of all size. As a Creative Director ,i am a problem solver at heart, and strive to deliver the most effective solution at the highest of standardsRead More »
creative Director
Art Director
event manager


text:
Results 1-3 of 3 for differential equations tutor shanghai
Differential Equations Tutors in Shanghai, China
Find Private & Affordable Differential Equations Tutoring in the Shanghai Area!
Kevin Z. Private Differential Equations tutor in Shanghai, China
I have been a tutor since my junior year in high school and continued throughout my 4 years in college . I recently graduated from Columbia University and will be a derivatives trader starting in September . I have interned in the fields of investment banking, private wealth...
Columbia University Class of 2014 B.Sc. Financial Engineering, Minors in Applied Math and Economics GPA: 3.7
Aria T. Private Differential Equations tutor in Shanghai, China
SAT Scores: Math 800 Writing 780 SAT II Math Level 2: 800 SAT II Physics: 800 Taken Full IB Diploma (HL in Math, Chinese, Physics) Taken AP Calculus BC, AP Physics C Mechanics and E&M (5 on all exams) Algebra, Calculus, Differential Equations, Geometry, Math,...
Mechanical Engineer at Stanford University, 4.0 GPA, Graduating 2016
Eric D. Private Differential Equations tutor in Shanghai, China
4 years of tutoring experience for Engineering and high school students(AP, SAT, IB, IGCSE). ACT Science, ACCUPLACER Elementary Algebra, ACCUPLACER College-Level Math, ACCUPLACER Arithmetic, ADHD, ADD, ACT Math, 11th Grade math, 10th Grade math, Accounting, 11th Grade math,...
Masters in Business Administration at Hult International Business School


text:
Santa Train grinds to a halt
Dublin commuters were left stranded for up to ninety minutes this afternoon - after Santa's steam train broke down.
It was a case of ho ho hum for DART users when a special family steam training carrying Mr Claus drew to a halt on the tracks.
The train, travelling from Dublin to Greystones, had sold out weeks in advance and was packed with families. The two-hour journey features an on-board visit from Santa and presents for children plug photo opportunities with the man himself.
But the busy Dublin commuter rail belt - being used by thousands of shoppers in the run-up to Christmas – ground to a halt when the vintage train experienced technical difficulties, blocking the busy track.
Red-faced Iarnrod Eireann chiefs even posted a picture on twitter of Santa being quizzed by officials about the incident.
It was the first special Santa railway trip of the season and the trains have proved to be a huge hit with families and young children. Services were restored following a ninety minute delay.


text:
Aryan (Sohail Khan) was born to fight. He is the college champ and under the tough training of Coach Ranveer Singh (Puneet Issar), he dreams of winning the nationals. Life takes a turn and Aryan chooses to give up his dreams and marry his love, Neha (Sneha Ullal), instead. They have a kid and start living a common man's life. He takes up a job as a sports commentator, but life is never the same for him and he hits a low professionally, as well in his married life. One day, his ex-coach asks him to get back into the ring and Aryan decides to follow his dreams again, but he isn't the man he used to be. Will Aryan be able to achieve his dreams?
330 total views, 2 views today


text:
Anthem Community Park
41703 N. Gavilan Peak Pkwy.Anthem, AZ 85086
See map: Google Maps, Yahoo! Maps
Frazier Shows' carnival and midway will be operating at Community Park as part of the Anthem Days celebration. All-you-can-ride wristbands available all evening. Pick up a coupon at the Anthem Civic Building or ACC Community Center for a $3 wristband discount.


text:
Barnegat Township officials say they are looking forward to work starting at a 110-acre site designated as a redevelopment zone once a buyer is identified at an auction next week.
The parcel of land adjacent to the Garden State Parkway on West Bay Avenue is one of the last tracts in the township zoned for residential development.
The property was most recently owned by Shoreline Sand and Gravel, which filed for bankruptcy a year and a half ago. On Sept. 24, the property will be auctioned off by Sheldon Good & Co. through a U.S. Bankruptcy Court bank-directed sale at the federal courthouse in Trenton, a news release states.
Bidding will start at a minimum of $600,000, the release states.
The township will not be bidding on the property, Administrator Dave Breeden said Monday. A portion of the property is zoned residential, and another area is zoned commercial, Breeden said.
"The township designated this as a suitable area for redevelopment, and at this point we're going to wait to see who the successful bidder will be," he said.
Evelyn Weiss Francisco, spokesman for the Walters Group, said Monday that the development firm also will not be bidding on the property. The Walters Group developed a large portion of a residential subdivision in Barnegat and neighboring Stafford townships.
The site will need a considerable amount of remediation and cleanup, following several outstanding violations from the state Department of Environmental Protection and Pinelands Commission, Breeden said. The process is expected to be time-consuming.
"We feel we have a fair amount of residential property already, and we would love to see something commercial come here that is suitable for the area," he said.
Contact Donna Weaver:
Follow @DonnaKWeaver on Twitter


text:
Peach & Lychee Opera Cake
200g margarine or butter
200g caster sugar
3 medium eggs
200g self-raising flour
¼ tsp almond extract
Peach Jam:
1 tin peach slices
150g granulated sugar
Peach & Lychee Buttercream:
70g softened unsalted butter
120g icing sugar
70ml Five Valleys Peach & Lychee Cordial
Lychee Chantilly Cream:
300ml double cream
20g icing sugar
½ tin of tinned lychees
100g white chocolate
60ml double cream
Few slices of tinned peaches
Few lychees from a tin
Few small basil leaves
Serves 8-10
1. Grease and line a baking tin about 32cm x 11cm in size and pre-heat the oven to 160C.
2. Make the sponge by creaming the margarine/butter with the caster sugar, then add in the eggs one at a time. Fold in the flour and almond extract. Add a little milk if needed to loosen the mixture.
3. Pour a quarter of the mixture into the baking tray and spread out evenly. The mixture should be a maximum of 1 cm deep.
4. Bake the sponge for approx.15 minutes until cooked through. Turn the sponge out to cool on a wire rack and cover with a tea towel to prevent it drying out.
5. Repeat this step until you have four sponges.
6. To make the jam, chop up the sliced peaches and place in a heavy-bottomed pan with the sugar. Place on a medium heat for about 20-30 minutes until the peaches have softened and the mixture has a familiar jam-like consistency. The jam will thicken as it cools.
7. To make the buttercream, simply cream the butter and icing sugar together, then add in the cordial and continue to mix until it is all combined.
8. For the lychee cream, whip up the double cream with the icing sugar until the cream is softly whipped. Then fold in the chopped tinned lychees.
9. For the ganache, warm up the double cream in a microwave in 30 second bursts until it begins to boil. Add in the white chocolate and stir until all the chocolate has melted. Refrigerate to allow it to cool and set slightly.
10. To assemble the cake, place one of the sponges on a board, then add a few large tablespoons of jam. Spread evenly, ensuring it reaches the edges – it doesn't matter if the jam spills over. Add another sponge on top of this and repeat with the peach and lychee buttercream. Place a third sponge and then a layer of the lychee cream. Finally add the final sponge and drizzle over the ganache, ensuring it covers the entire top of the sponge. Put this into the fridge to set for an hour.
11. After an hour, take your opera cake out of the fridge and with a sharp knife, trim off the edges of the cake on all four sides about ½ cm in. This will give you crisp, neat lines, highlighting the layers.
12. To garnish, top with slices of peach, sliced lychees, and small basil leaves.
Recipe courtesy of Five Valleys Cordials
Find us on Twitter Facebook Pinterest Google+ Bloglovin'


text:
Basetsana Kumalo injured
Basetsana Kumalo was supposed to Judge Miss SA airing on Saturday, and she slipped and fall and broke her ankle at her Son's school after seeing him perform at a concert.
Miss SA website announced and wrote in a sa
"Miss South Africa regrets to announce that Basetsana Kumalo, one of the judges for this year's Miss South Africa pageant, had an unfortunate accident yesterday at her son's school after watching him play at a concert. She slipped in the rain and broke her ankle and is currently in hospital undergoing surgery. The organisers have made the decision not to replace her on the judging panel at this late stage and her scores to date still stand,"


text:
- Outstanding ROCKER, insane maneuverability and control in the surf construction
- Amazing feeling and versatility while riding!!!
- Nose channel
- Front pad kick
- Compact grab rail
Full pads
Fins FUTURES®
Box FUTURES®
F-ONE surf straps (in option)
|162 x 46 cm
|167 x 46.5 cm
|3.10 kg*
|3.25 kg*
*indicative value, subject to small variations due to the custom manufacturing process.
"Mitu rides the same board on flat water, small onshore waves, extreme offshore conditions and just free surfing "
Since the first MITU PRO MODEL 4 years ago, we have focused on one single objective: offer the best technology to bring unique sensations and exceptional comfort.
The Mitu boards have become genuine technological marvels featuring many built-in features: HD FOAM FLEX COMPOSITE, HEEL SHOCK ABSORBER, full pads…
For the ESL version, we have elected to use our original BAMBOO SANDWICH CONSTRUCTION, which was an F-ONE innovation and a tremendous success.
ESL stands for ESSENTIAL as this is all we have kept for this original technology. Fitted with a full bamboo sandwich on both deck and bottom with double bamboo layer on deck to strengthen the area under your feet, the board is very resistant to local impacts and offer a great comfort.
Without pads for the riders who prefer a direct contact with the board and use some wax, this board also shares the latest shape and design of the Mitu range.
The 2017 PRO MODEL MITU MONTEIRO range is the 4th edition of this bestseller!
Those high performance boards especially designed for strapless riding became a reference on the market in just a few years.
This year, the range receives two new models: the ultra-light CARBON version and the ESSENTIAL version!
Throughout the years, Mitu has acquired an impressive experience and expertise while being a clear pioneer of strapless riding. Having a really good feel for the gear with some sharp analytical skills and a lot of curiosity, he got totally involved in the development of his pro model. Mitu also likes to try a lot of different boards while kiting but also for surfing. His approach therefore stays true to F-ONE's ethos of creating products that are high performance but always remain ultra-versatile.
The MITU MONTEIRO PRO MODEL receives the proven HD FOAM FLEX COMPOSITE construction which improves the board so much thanks to its flexibility and comfort. This includes a high density foam sandwich, with optimized flex to improve reliability, provide outstanding comfort and better maneuverability while keeping the boards lighter.
The HEEL SHOCK ABSORBER featured on the deck softens all impacts and landings for the rider while increasing the board durability. Mitu used to like longer boards because of the added stability they offer. With the compact outline and the rounded nose, we have achieved a shorter board which keeps some great directional stability.
The outline is designed to make the tricks easier and get a more responsive board. Yet the boards remain rather wide to get a lot of lift and make the most of the waves' energy. Looking at the bottom, we have used a very deep single concave that extends all the way back to the fins. This guarantees an early planning with sharp accelerations on and off the surf while helping out dealing with the chop.
For 2016 the two smaller sizes, which include the 5'6 and a new 5'4, benefit from a bit more rocker on the tail to achieve more maneuverability and control, especially in the surf. On the other side, the two larger sizes, 5'8 and 5'10, the concave has been reduced slightly around the fins to make the board easier and more progressive in the turns and while carving. The Mitu MONTEIRO boards are all equipped with a tri-fin setup for a faster ride and a lighter weight for the tricks.
On deck, the CAMEL DECK shape helps nesting your feet into the board for an incredible control while the grab rail at the front will help out during the tricks.
By testing it on all the different spots of his island Mitu pushed hard to develop a truly innovative range of boards which excels in all kind of riding. A typical day usually includes some freestyle at Kite Beach in the morning, followed by a kite wave session in Ponta Preta in the afternoon, before a late surfing session in the evening when the wind has gone. And doing it all with the same board does not seem to take anything off his impressive riding level!
How many surfers have broken boards and wished they could replace it with a new one and get the same sensations they are used too?
Mitu once asked me:
Raph, can you try this board and make me the same one; it feels really good under my feet
I went out and tested this strapless board and was astonished by the control and sensations that the board gave me.
After a few runs, I started analyzing what was giving me this sensation of control. I realized that my front foot was nestled in a heel dent and that my arch was fully supported on the rounded deck. I could see that Mitu had spent so many hours on the board, that it had taken the shape of his foot.
I then understood that I needed to make a board with the top deck pre-shaped to get this sensation on a new board.
With its unique design, the CAMEL DRIVE DECK will offer multiple advantages: It will lower and stabilize the heel of the surfer and lock its arch on a rounded center line. It will improve stability, maneuverability and increase the rider's board control in any conditions.
The introduction of this new construction represents a major change into the F-ONE surfboard range: the two Key products (MITU MONTEIRO & SIGNATURE) are now dispensed with bamboo.
To face the ever higher constrains applied by the riders on their surfkites, F-ONE has engineered a new foam composite construction with optimized flex, for maximum reliability, comfort and maneuverability.
The mechanical characteristics achieved by this construction provide a lighter weight and a perfect surfboard feel.
The deck has been recessed by 5 mm on a wide area underneath the front foot in order to add an EVA shock absorbing foam layer.
This foam layer absorbs effectively all impacts for the rider and makes the board even more durable.


text:
A sparkling array of silver settings adorned with natural stones. The chunky amber collection alone is worth checking out. Pieces here are surprisingly original and won't clean out your wallet.
Area Rome
Transport Bus 23, 280, 780, H/tram 8 .
Telephone 06 589 6891
Open 10am-8pm Mon-Sat. Closed 1wk Aug.


text:
Apartment Features
- Air Conditioning
- Balcony
- Cable Ready
- Ceiling Fan(s)
- Dishwasher
- Microwave
- Oversized Closets
- Some Paid Utilities
- Washer & Dryer In Unit
- Patio
- Refrigerator
Special Features
- Disability Access
Community Features
- Emergency Maintenance
- Extra Storage
- Fitness Center
- High Speed Internet Access
- Swimming Pool
- Trail, Bike, Hike, Jog
- On Site Management
- Pet Friendly
Additional Features
- Walking Trail
- Storage Room with Floor to Ceiling
- Walk in Pantry
- Spectacular Landscaping
- Friendly staff
- Courtesy Officer on-site
- Water/Sewer and Trash Removal furnished
- No Pets
Floor Plans & Pricing
Prices and availability subject to change without notice.
Property Details
Mark VI Apartments
Our mission is to be the mark of excellence in apartment living. We provide six locations near the heart of town to give you a quality living experience. Whether you are a longtime Hattiesburg resident or a new student at the area Universities, we can provide you with a space that will very quickly become a home. By choosing one of the Mark Apartments complexes, you are choosing to live with the assurance of prompt maintenance service and an attentive management team. You are choosing to be near to the cultural aspects of Hattiesburg that make it the "Hub City," like the Longleaf Trace and the newly revitalized downtown area. We would love to have you become a resident and experience the best of Hattiesburg apartment life!
Lease Terms
6-Month, 12-Month
Office Hours
Closed Today
Ratings & Reviews
General Directions
Please call for directions.
Helpful Information
Fax: 6012619133
Visit the property's management website


text:
CVCC Conference Center
- 0 Comments
In Fall 2014, Children's opened the Dr. Harold Katkovand Dr. H.K. Helseth, Jr. Cardiovascular Conference Center. This state-of-the-art facility provides care providers a place to learn about the latest technologies and continue their professional development to best serve our patients and families.
We are pleased to feature landscape photography by Minnesota artists in the new Conference Center. This artwork is available for sponsorship, and we invite you to join us in making this space feel warm and welcoming to all who will use it.


text:
An engagingly ramshackle adventure that gradually takes on a burden of messages as Reynolds and Carmel latch on to Susan Clark's archaeological expedition, which has permission to explore the New Guinea interior. The pair are secretly prospecting for phosphorus (highly profitable since the advent of colour TV), but instead find a tribe of ape-like, intelligent creatures (played by diminutive University of Djakarta students in gingery, hairy suits) who may be 'the missing link'. Dropouts one and all, they certainly believe in flower-power, which turns Reynolds all radical when the Establishment - in the shape of the archaeological expedition's financial backer - proposes to breed them like animals for cheap labour. Cue for a rousingly melodramatic courtroom finale, engineered in desperation by Reynolds, in which the definition of 'humanity' comes under hot debate from all sides (Black Panthers, apartheid apologists, et al). Naïve, uncertain in tone, but despite all faults, an appealing curiosity.
Release details
|105 mins
Cast and crew
|Gordon Douglas
|Nelson Gidding
|Burt Reynolds
Susan Clark
Roger C Carmel
Paul Hubschmid
Chips Rafferty
Alexander Knox
Edward Fox
Wilfrid Hyde-White


text:
He fills her up with hard dick in the stairwell after paying for it
Tags: amateur couple creampie doggy hd high heels homemade
Angela Attison Fills Her Pussy Up With Smoothie
Tags: big tits blondes pornstars pussy
Cute teen rips off her clothes and fills her pussy up with t
Tags: clothes off cute masturbation pussy teens toys
She Loves The Way Cock Fills Up Her Tight Pussy
Tags: asian doggystyle hd pornstars small tits tight pussy
He Fills Her Pussy With Cum black ebony cumshots ebony swallow interracial
Tags: amateur black cum cumshots ebony interracial pussy
Hot milf takes her husbands hard cock deep in her pussy until he fills her with a huge load of hot semen that gushes out of her tight cunt
Tags: amateur couple creampie cumshots cunt hardcore homemade
He Fills Her Mouth With Cum!
Tags: amateur blowjobs couple cum cumshots handjobs hardcore
He fills her asshole with hot cum
Tags: anal asshole blowjobs couple creampie cum high heels
He fills her shaved muff with cock meat
Tags: amateur doggystyle fingering hd milf shaved
The old guy fills up her up with his mature cock on his couch
Tags: amateur babes blondes classy doggystyle glamour matures
Golden babe Arwen Gold fills up her twat and her ass
Tags: anal ass babes brunettes masturbation toys
He picks up and bangs her fat pussy
Tags: ass bbw boobs chubby chunky fat group sex
He cant get enough of her pregnant body as he feels her up
Tags: asian big tits brunettes fetish masturbation oriental pregnant
Bonita fills up her butterfly with hard cock
Tags: big tits blowjobs couple cum ebony masturbation office
She fills up a bowl with his cum from her twat
Tags: blowjobs brunettes couple creampie cum interracial oral
His throbbing cock fills her ass up with ease on the boat
Tags: amateur anal ass assfucking boat brunettes buttfucking
He picks up a chick on the bench and toys her before he pum
Tags: anal asian japanese stockings toys
Super sexy girl in black stockings fills up her holes with sex toys
Tags: black fetish stockings toys
Japanese teen Karin Tsubaki is in a warehouse with her bald headed fuck buddy. He yanks up her jean mini-skirt and pulls down her lacy push up bra let
Tags: asian big tits bra dick hardcore japanese pussy
Candy Cat fills her pussy with her dildo
Tags: amateur babes beauty brunettes candy cat dildo homemade
Mother and young girl He was hired to do her make-up, but he did a lot
Tags: blowjobs cumshots hardcore old young piercing redheads shaved
Hot slut Claudia Downs fills her mouth with a juicy dick until she chokes up
Tags: blondes claudia downs dick interracial juicy matures
He Fills Both Holes
Tags: amateur anal interracial
TrafficHolder.com - Buy and Sell Adult Traffic|Trafficshop.com - Let your business grow|Contact Us|Webmaster
All content, including images, text, graphics, video and audio content contained in the website is protected under the laws of copyright, owned or under license to company or its designees,and represents proprietary and valuable intellectual property.
Contact Webmaster 18 U.S.C. 2257 Record-Keeping Requirements Compliance Statement
Powered by Stream Rotator


text:
Pain Centers Of Iowa
Davenport, IA 52807
About Pain Centers Of Iowa
Welcome to Pain Centers of Iowa!
Pain Centers of Iowa serves the Quad-City community and surrounding areas by providing relief within reach. Led by John Dooley, M.D., who is board-certified in Anesthesia, Critical Care Medicine and Pain Management, we are leaders in identifying pain generators.
Dr. Dooley, who has been practicing in the Quad-Cities since 1996, develops a personalized pain relief program for each of his patients after a full pain assessment at consultation. We strive to be pioneers in the advancement of pain management techniques. We continue to be informed and trained in new methods and technology.
Pain Centers of Iowa offers a multitude of services, but we specialize in treating back pain patients and performing Kyphoplasty to remedy Osteoporosis-related fractures. We also are leaders in treating bone health management, Osteoporosis management, sports injuries and tendon injuries. Additionally, we offer a unique platelet-rich plasma therapy for bioregenerative purposes. Recently, we just started providing a new FDA-approved therapy that is designed to relieve chronic back pain that patients continually suffer after undergoing a back surgery.
At the innovative Pain Centers of Iowa, our focus is on you and what is causing your pain. Millions of people suffer with chronic pain in the United States, a growing area of concern and focus in our community. Dr. Dooley has been treating pain for more than 25 years and continues to be a pioneer in the field of pain management. It is his belief that, "It is important to be technologically prepared in this evolving challenge to keep patients ahead of their pain."
To best serve our valued clients and provide the best possible customer care, we have three offices in Iowa. In Davenport, we are located at 5515 Utica Ridge Road, Suite # 600. Our phone number is (563) 344-1050 and our fax is (563) 424-4579. We also have additional sites in Burlington and Coralville. Our Burlington office is located at 903 Oak Street, while our Coralville site is positioned at 2180 Norcor Avenue, Suite B.
For more information, you can visit our website at: www.pcipain.com. You also can connect with us via email at: firstname.lastname@example.com.
Pain Centers of Iowa is contracted with most insurance companies and works with physicians who refer their patients to us. We are open Monday through Thursday, from 8:00 a.m. to 4:30, and on Friday from 8:00 a.m. to 3:00 p.m. We accept all major credit cards, cash and checks.
At Pain Centers of Iowa, our focus is on the cause of your pain. This determines the best interventions and paths to take so patients can get their lives back. Not every patient has the same response to pain, either physically or emotionally. We are here to evaluate and support your condition through innovative interventions and combined community support as may be indicated. You are unique, so are your responses to your pain. Your pain is very personal to you, we understand this. We can help you live a better quality of life. Pain is frequently a constant battle and we look forward to intervening and supporting you through this challenge at Pain Centers of Iowa.
About Dr. John B. Dooley
John B. Dooley, MD, Bachelor of Science in Zoology, Iowa State University, Ames, Iowa (1976-1980). Dr. Dooley received his Doctor of Medicine at the University of Iowa, Iowa City, Iowa (1980-1984). He continued with his Residency in Anesthesiology at Hartford Hospital, Hartford, Connecticut (1985-1987). Dr. Dooley then continued with his Critical Care Medicine Fellowship at the University of Iowa, Iowa City, Iowa (1987-1988).
Board Certifications: Anesthesiology (1988), Critical Care Medicine (1989) & Pain Management (1996).
Organizations/ memberships
• American Academy of Pain Management
• American Medical Association
• American Society of Anesthesiology
• American Society of Interventional Pain Physicians
• International Spinal Injection Society
• North American Spine Society
• Iowa Medical Society
• Iowa Society of Anesthesiologists
• Scott County Medical Association
To schedule an appointment in Davenport, call us today at (563) 344-1050!
Our Services
Following are our primary services:
• Vertebral Augmentation/ Kyphoplasty (Osteoporosis Fractures)
• Platelet Rich Plasma Therapy (Bioregenerative)
• Spinal Cord Stimulators (Chronic Pain)
• Intrathecal Pain Pump Implant (Chronic Pain, Cancer Pain)
• Ketamine Infusion (Chronic Pain)
• Orthovisc Joint Injection (Degenerative Knee Arthritis)
• Ultra-Sound Guided Injections
• Epidural Blood Patch
• Transforaminal Steroid Injection (Cervical, Thoracic & Lumbar)
• Trigger Point Injections (Muscle Pain)
• Sacroiliac Joint Injections (Low Back Pain)
• Peripheral Nerve Blocks (Extremity Pain)
• Sympathetic Nerve Blocks (Extremity Pain)
• Occipital Nerve Blocks (Upper Neck Pain)
• Medial Branch Blocks (Spinal Pain)
• Facet Injections (Spinal Pain)
• Radio Frequency Lesioning (Spinal Pain)
• Manual Therapy (Muscle Pain)
• Botox for Migraines
• Genicular Nerve block (G-Block)
• Genicular Nerve Ablation (RF Neurotomy)
Pain Centers of Iowa
- Accepts:
- American Express
- Cash
- Check
- Discover
- MasterCard
- Visa
Pain Centers Of Iowa Offers Platelet Rich Plasma Therapy
Pain Centers of Iowa
For people who suffer chronic back pain after a back surgery, we now are providing a new FDA-approved therapy to treat this continual pain. Stop in and see us today at 5515 Utica Ridge Road, Suite 600, in Davenport.
Pain Centers of Iowa
Come visit Pain Centers of Iowa today at 5515 Utica Ridge Road, Suite 600, in Davenport. We specialize in treating patients with back pain and performing Kyphoplasty procedures to remedy osteoporosis fractures.
Pain Centers of Iowa
Contact Pain Centers of Iowa today at (563) 344-1050. We take care of bone health and osteoporosis management for our patients.
Pain Centers of Iowa
Pain Centers of Iowa, located at 5515 Utica Ridge Road, Suite 600, treats patients for sports injuries and tendon injuries.
Pain Centers of Iowa


text:
Fixed Cam CollectionFavorites [+]
Pay-Per-Minute Viewing
You can now enjoy this movie on your iPhone®, iPad®, or compatible Smart TV & Android devices.
Purchase Options
Pay-Per-MinutePurchase Minutes
Streaming Rentals
Available MP4 sizes:SD 480p (0.68 GB)
DRM-free downloads offer content that is not limited by standard Digital Rights Management (DRM) access technologies. These technologies allow hardware manufacturers, publishers, copyright holders and individuals to limit the usage of digital content.
When you purchase DRM-free downloadable content, that content is available for you to download on any computer and save to a disk whenever you like. You can also download to multiple computers. There is no timeframe associated with your purchase and the content will not expire.
Running Time: 47 minutes
Studio Name: Femorg
Series: Real Female Orgasms - Femorg
Categories: Amateur Masturbation All Sex All Girl
Description: We've learned that some our customers like the camera roving and some of them like the camera stationery. If you fall into the latter group, then this is the ultimate DVD for you! Eight of our gorgeous, favorite, orgasmic women were captured wanking away to ten awesome orgasms and we created a special compilation to share with you!
8 Scenes from Fixed Cam Collection
Fixed Cam Collection: Scene 1 Free Preview
Starring: Myla ... More Details
Stars: Myla
Fixed Cam Collection: Scene 2 Free Preview
Starring: Myla ... More Details
Fixed Cam Collection: Scene 3 Free Preview
Starring: Zahra ... More Details
Fixed Cam Collection: Scene 4 Free Preview
Starring: Louisa (FemOrg) ... More Details
Stars: Louisa (FemOrg)
Fixed Cam Collection: Scene 5 Free Preview
Starring: Jo-May (FemOrg) Jean (FemOrg) ... More Details
Stars: Jo-May (FemOrg), Jean (FemOrg)
Fixed Cam Collection: Scene 6 Free Preview
Starring: Roxanne ... More Details
Stars: Roxanne
Fixed Cam Collection: Scene 7 Free Preview
Starring: Roberta (FemOrg) ... More Details
Stars: Roberta (FemOrg)
Positions: Sitting
Settings: Living Room
Fixed Cam Collection: Scene 8 Free Preview
Starring: Elle Brook ... More Details
Recommended Movies
AEBN Cams


text: Complete that look that you desire with our fantastic award winning modern and contemporary furniture and brighten up your home with this stunning sofa bed. Hand crafted and carefully built to the highest quality, this sofa bed featuring a two tone black and grey colour will be sure to amaze. Perfect for providing both extra sleeping space and comfy seating, this sofa will become an instant favourite brightening up your home in an instant.


text:
Qtys Available: 50 lb multi-wall bag with poly liner
Product Selling Points:
Magnum is an all-natural supplement that combines the benefits of active live yeast with Enzabac's time-tested bovine-specific bacteria and enzymes.
Feeding Directions:
- Feed ½ oz/head/day, according to your nutritionist's recommendation
Store in a cool, dry place protected from light and moisture. Keep out of reach of children.
Caution: Follow label directions. The addition of feed of higher levels of this premix containing selenium is not permitted.
Processed Grain By-Products, Grain Products, Calcium Carbonate, Active Dry Yeast, Dried Lactobacillus acidophilus fermentation product, Dried Enterococcus faecium
fermentation product, Dried Bacillus subtilus fermentation product, Mineral Oil.
Due to many variables beyond our control, ENZ-A-BAC ADVANCED PRODUCTS, INC. makes no warranties expressed or implied, concerning this product or its use beyond the description on the face hereof. In no event shall ENZ-A-BAC ADVANCED PRODUCTS, INC. be responsible for consequential or incidental damages.


text:
|Product Profile
Sometimes, even the best of street fighters can feel a little limp and lackluster. Power up your punches and crank up your kicks with this delicious Street Fighter Sonic Boom energy drink! Packed full of caffeine and sugars to keep you floating like a butterfly and stinging like a bee, this energy drink was inspired by Guile�s iconic movie, so you know that it will help you to stay on top form all day long.


text:
Internal Audit And Management Audit
Audit, a specific term, is defined as a planned and documented activity or an official investigation and evaluation of the accounts of an organization to determine the adequacy and compliance with pre-established procedures or the documents, which are applicable, and the effectiveness of implementation. It is a vital part of accounting. It is thorough examination and evaluation of an organization's financial statements without any prejudice. Among the different types of Audit that we have come to know, Management Audit Internal Audit Services also has profuse amount of importance in the world of audit.
Internal Audit:
Internal Audit which is also known as a first-party audit, is the auditing by organization of its own systems, i.e. self assessment which is ultimately used to ascertain the strengths and weakness against requirements, and an organizations own standards. Internal Audit is an activity, which is independent, objective assurance and consulting, designed in a way that, at an end it adds value and improve an organization's operations. By bringing a systematic, disciplined approach to evaluate and improve the effectiveness of risk management, control and governance process, it helps an organization to achieve its objectives. There may be some potential threats to the organization's health and profitability. Thus internal audit is designed to review what a company is doing in order to identify those threats, and to make suggestions to reduce the risk that are directly or indirectly associated with those threats in order to minimize costs. Professionals called Internal Auditors, who are employed by organizations, perform Internal Auditing Services.
Some of the major roles and responsibilities of Internal Audit functions are:
- Draws conclusions from examinations and provides reasonable assurance or certainty that management of risk, control and governance systems are functioning, as it was intended and will enable to meet the goals and objectives of an organization.
- Reports internal control deficiencies and risk management issues identified directly to the audit committee and furnish advice for ameliorating the organization's operations in terms of both efficient and effective performance.
- Evaluates information security and related risk exposures.
- With consultation of legal counsel, evaluates regulatory compliance.
- Evaluates preparedness of the organizations in case of business interruption.
- Establishes accessible communication with management and the audit committee.
- Participates in continuous education and staff development
- Provide aid to the company's anti fraud programs.
Management Audit:
Changes in the business environment are inevitable. Some changes are major and these are the causes for which Management audit is necessitated in the business. The utter inspection and evaluation of competencies of a company's management in order to evaluate their effectiveness, especially regarding the strategic objectives and policies of a business is what we know as Management audit. The primary objective for the management audit consultants is to analyze the management team in relation to their competition. Thus, we can conclude that it is not necessarily done to appraise individual executive performance. It is a systematically done examination of the decisions and actions of the management to analyze the performance. Some of the managerial aspects like organizational objective, policies, procedures, structure, control and system, are reviewed by the Management Audit Consultants. It is basically done to check the efficiency of performance of the management over the activities of the company. It is generally conducted by the employee of the company or by the independent consultant and concentrated on the crucial evaluation of management as a team rather than appraisal of individual.
Some of the major roles and responsibilities of management audit are:
- Identifying the objectives of an organization if such are not set up.
- Allocating the overall objectives of an organization into small fragments.
- Reviewing the whole structure of an organization and asset of an organization deciding whether the target can be achieved or not.
- Examining all the scope of work and liability centers.
- Helping the members of management to make effective discharge of duties
- Helping in the improvement of profits.
By - Uttam Neupane


text:
Tumbling emerging markets currencies from India to Indonesia to Brazil to Turkey are having an adverse impact on eager yen bears that had been hoping for more weakness out of the Japanese currency.
In the past month, the the WisdomTree Emerging Markets Currency Fund (NYSEArca: CEW) has lost nearly 3% while the CurrencyShares Japanese Yen Trust (NYSEArca: FXY)is just fractionally lower. The yen could be in for further upside, pressuring equity-based Japan ETFs in the process, as currency traders seek out safe-haven alternatives to the U.S. dollar. [Emerging Market Currency ETF Perks Up]
With turbulence seemingly escalating by the day for currencies such as the Indian rupee, Indonesian rupiah and others, traders are increasingly looking for other currencies to embrace in addition or instead of the U.S. dollar. In addition to the yen, the British pound has also been lifted as emerging currencies have wilted. Sterling has perked up against riskier, commodities-expose currencies to trade higher against many of the emerging Asia-Pacific currencies in recent days. [New ETF Shows Intimate Correlation to British Pound]
As for the yen, the currency is a favored safe-haven destination during times of market stress. That scenario is repeating itself due to at least one obvious reason: Japan is not addicted to external financing to run its deficits. Additionally, Japan has a current account surplus. It is current account deficits that are straining currencies like the rupee and rupiah while sending investors out of Indian and Indonesian stocks. [A Bright Spot for India ETFs]
Earlier this month, Japan reported a smaller-than-expected current account surplus, but the fact remains the country has a surplus at a time when that is a highly prized economic trait.
Although Australia has an AAA credit rating, volatility in the Australian dollar has been rising ahead of next month's national elections. Lack of clarity on the time line for Federal Reserve tapering could pressure the greenback. Any retrenchment in oil prices would weigh on the Canadian dollar. Those scenarios also highlight the yen's safe-haven allure.
Japanese equity bulls are left to hope that the yen's status as a shelter from the storm play is short-lived because in the past month, iShares MSCI Japan ETF (NYSEArca: EWJ) and the WisdomTree Japan Hedge Equity Fund (NYSEArca: DXJ), two of this year's most prolific asset-gathering ETFs, are each down about 1.7%.
CurrencyShares Japanese Yen Trust
ETF Trends editorial team contributed to this post. Tom Lydon's clients own shares of DXJ.


text:
Solo Girls Mania: HelenFavorites [+]
Pay-Per-Minute Viewing
You can now enjoy this movie on your iPhone®, iPad®, or compatible Smart TV & Android devices.
Purchase Options
Pay-Per-MinutePurchase Minutes
Streaming Rentals
Available MP4 sizes:SD 480p (0.28 GB)
DRM-free downloads offer content that is not limited by standard Digital Rights Management (DRM) access technologies. These technologies allow hardware manufacturers, publishers, copyright holders and individuals to limit the usage of digital content.
When you purchase DRM-free downloadable content, that content is available for you to download on any computer and save to a disk whenever you like. You can also download to multiple computers. There is no timeframe associated with your purchase and the content will not expire.
Running Time: 18 minutes
Released: 04/2014
Studio Name: MVG Productions
Series: Solo Girls Mania
Categories: Euro Masturbation Small Tits International All Sex All Girl
Description: Helen uses toys to make herself cum and then tastes her juices!
1 Scenes from Solo Girls Mania: Helen
Solo Girls Mania: Helen: Scene 1 Free Preview
Starring: Helen ... More Details
Sex Acts: Breast Play, Masturbation
Positions: Crouching/Squatting, Standing, Sitting, Laying, Kneeling
Settings: Living Room
Studio: MVG Productions
Recommended Movies
AEBN Cams


text:
Competition Heats Up As Race Teams Prepare For Chili Cookoff At Texas Motor Speedway FORT WORTH-DALLAS (Oct. 7, 2004) -- If the competition on the track isn't hot enough, Indy Racing League IndyCar Seriesâ teams will take it to a new level...
Competition Heats Up As Race Teams Prepare For Chili Cookoff At Texas Motor Speedway
FORT WORTH-DALLAS (Oct. 7, 2004) -- If the competition on the track isn't hot enough, Indy Racing League IndyCar Seriesâ teams will take it to a new level with the first IRL Texas Chili Cook-Off presented by Pioneer on Friday night, Oct. 15 in the infield competitor RV area of Texas Motor Speedway.
Pioneer is sponsoring the season ending event that will have some of the best drivers in the world behind a stove instead of a steering wheel.
"Chili cook-offs and Texas go hand in hand," said speedway president Eddie Gossage. "We think it's a great idea, although I'm not sure I want to be a judge for this thing. I'm thinking some of these guys are probably better drivers than cooks."
Each race team may enter one team into the chili competition. 2004 Indy 500 winner Buddy Rice and Team Rahal were the first official entrants. Even recently retired Al Unser Jr. will take part, entering his grandmother's famous recipe for "Mom Unser's Chili" which was once an Indy 500 tradition.
"This is a great way to end a really 'hot' season. Who knows, it may turn out to be the first of many chili cook-offs at Texas Motor Speedway," said Susan Harrison, spokesperson for mobile entertainment at Pioneer Electronics (USA) Inc. "In case fans don't like Buddy's chili, I'm certain Pioneer's navigation system can locate a great chili restaurant somewhere in Texas!"
The closed event, which will serve as the season ending party for teams, series officials and special invitees, will include live music and prizes. The event is slated to begin at 6:30 p.m. following qualifying for the Chevy 500k. The judges will tally their votes with the winners being announced at 8 p.m.


text:
CyberCapture - Frequently Asked Questions
What is CyberCapture?
CyberCapture is a feature of Avast that detects and analyzes rare, suspicious files. If you attempt to run such a file, CyberCapture locks the file from your PC and sends it to the Avast Threat Labs where it's analyzed in a safe, virtual environment. You are notified when the analysis is complete.
What conditions lead to a file being uploaded by CyberCapture?
Currently, CyberCapture triggers when you run or download suspicious files from the Internet that CyberCatcher has not previously encountered. We plan to expand this condition in the future to cover more sources.
What happens if a large file is uploaded by CyberCapture?
CyberCapture is able to handle large files, but it may take longer to deliver such files to the Avast Threat Labs.
How does Avast protect my privacy if my file is uploaded by CyberCapture?
All files are uploaded over an encrypted connection, which means your data is inaccessible to hackers.
How do I enable or disable CyberCapture?
CyberCapture is enabled by default in the latest version of Avast. For instructions on how to update the Avast program version, read the following article:
We strongly recommend that you keep CyberCapture enabled. If you would like to disable CyberCapture, open the Avast user interface and go to Settings. Untick the box next to Enable CyberCapture.
We are sorry, unfortunately this article is not available in the selected language. Would you like to continue reading the article in the current language or go to our home page in the language you have just selected?Continue reading Go to Home page


text:
In the round up this week: looking at the big picture gives us an idea of the issues at hand – but it's the close up, the personal stories, that motivate us to take action. It's all well and good to share the cold hard facts but if your goal is to change behaviors: a story with no emotional heart has got no legs. Here I've gathered a few good examples, from the past week's news, of how taking a look at the micro can make the macro seem more urgent than big numbers alone.
If you're a science communicator or educator at an informal science center (such as a zoo, aquarium, or museum) trying to encourage conservation action – this is the round up for you! Every Friday we break down the week's most interesting news and best resources to help you frame the issues as effectively as possible.
Climate change and human displacement
Big picture: Climate change 'will make hundreds of millions homeless'
Scientists predict that rapid warming of the planet will massively disrupt weather patterns and spread deserts – "hundreds of millions of people" will be displaced from their homes due to crop failure and other stressors. Obviously this is a huge concern for both governments and social justice advocates. How will nations manage the influx of 'climate refugees' and make sure that they're treated humanely? How will health and feelings of social unrest be dealt with?
Related: The Global Estimates report revealed 32.4 million people were forced to flee their homes in 2012 by disasters; 98% of these displacements were related to climate- and weather-related events.
Close-up: America's first climate refugees
The Guardian talks to residents of Newtok, Alaska, mostly Yup'ik Eskimos. They face a choice that more than 180 native communities in Alaska are facing… do they stay in their ancestral homes? Or do they flee due to the climate-related flooding and erosion and risk their lives?
Sabrina Warner keeps having the same nightmare: a huge wave rearing up out of the water and crashing over her home, forcing her to swim for her life with her toddler son.
"I dream about the water coming in," she said.
It's an impactful story of real people being affected by climate change here, now.
The cost of environmental disasters
Big picture: Climate-related disasters cost American taxpayers $96 billion last year
This figure comes from a new analysis by the National Resources Defense Council – it works out to a shocking $1,100 per taxpayer. The reason? Climate-related disasters like Superstorm Sandy, droughts, floods, and forest fires. What could we do with that $96 billion to prevent climate change rather than use it to clean up the mess after the fact?
Close-up: Psychological scars run deep after BP oil spill
Beyond the money it costs to clean up environmental disasters, the human pain and suffering is immense. Relief efforts tend to be one-size-fits-all, but the huge number of people involved and wide variety of needs, make this an ineffective strategy. In particular, the coastal communities of Louisiana suffered greatly from a disrupted environment – loss of livelihoods and lack of appropriate help after the oil spill led to residents' stress levels rising in the year following the spill. There are real, long term impacts on people's physical and emotional well being after these events.
Related: New Study: The Economic Benefits of EPA Regulations Massively Outweigh The Costs. What more needs to be said? The study found regulations imposed as much as $45 billion in costs on the economy, but then drove as much as $640 billion in benefits. The Deepwater Horizon oil spill was much more of a "job killer" than the regulations that would have kept the rig safe to operate – or keep it out of the Gulf of Mexico altogether.
How do you communicate with your audiences about the big picture and the close ups of environmental issues? When you talk about an issue – do you always include a real personal story as well, or do you keep it more general? Further than that, do you feel like you're overstepping your bounds if you go further than just presenting the facts?


text:
Advances in An+coagula+on
- Melissa Virginia Dalton
- 1 years ago
- Views:
1 Advances in An+coagula+on Laurajo Ryan PharmD, MSc, BCPS, CDE Clinical Associate Professor The University of Texas at Aus+n College of Pharmacy UTHSCSA School of Medicine Pharmcotherapy Research Educa+on Center
2 Accredita+on & Disclosures Advances in An+coagula+on is accredited for 1.5 contact hours by: ACPE for pharmacists, ACPE L01- P Technicians, ACPE L01- T Laurajo Ryan has not disclosed any financial or conflicts of interest in rela+on to this program
3 Learning Objec+ves By the end of this session, the par+cipant should be able to: Review recent developments in an+coagula+on therapy List the key prescribing points and safety concerns for new an+coagulants Iden+fy op+ons for reversal of new an+coagulants Discuss transi+on between new an+coagulants
4 Thromboembolisms: The Problem United States Precise numbers unknown Es+mated at K/year 1-2/1000 1/100 >80 YOA Mortality K/year 25% of pa+ents with PE present with sudden death ½ with DVT Long- term complica+ons 10 years ~33% recurrence CDC: hcp://www.cdc.gov/ncbddd/dvt/data.html
5 An+coagulan+on Does newer = becer?
6 An+coagula+on Cascade Adapted from: Ryan. In Acridge, Miller, Moote, Ryan eds. Internal Medicine: A Guide to Clinical Therapeu+cs. McGraw- Hill 2013
7 An+coagulants Warfarin (Coumadin ) Inhibits clokng factors Heparins II, VII, IX, X Proteins C & S Unfrac+onated (UFH) Factor IIa Xa Low Molecular Weight (LMWH) Factor Xa >>> IIa Factor Xa inhibitors Fondaparinux (Arixtra ) Rivaroxaban (Xarelto ) Apixaban (Eliquis ) Edoxaban (Savaysa ) Direct thrombin inhibitors Argatroban Bivalirudin (Angiomax ) Dabigatran (Pradaxa )
8 An+coagulant Site of Ac+on Adapted from: Ryan. In Acridge, Miller, Moote, Ryan eds. Internal Medicine: A Guide to Clinical Therapeu+cs. McGraw- Hill 2013
9 An+coagulants Does newer = becer?
11 Warfarin Pros Many years of clinical data Ability to monitor effect Reliable reversal agent Vitamin K Cheap Once daily dosing
12 Warfarin Cons Inferior bleeding profile in some studies Delay in an+coagula+on ac+on Monitoring requirements Drug/diet interac+ons Gene+c variability
13 Risks & Reversibility Bleeding risk with INR GI tract Cerebral hemorrhage Elderly at higher risk An+dote Vitamin K Fresh frozen plasma FFP Prothrombin complex concentrate (II, VII, IX, X) PCC Recombinant factor VIIa Chest 2012;141(Suppl 2):e152S
14 FACTOR Xa INHIBITORS
15 An+coagulant Site of Ac+on Adapted from: Ryan. In Acridge, Miller, Moote, Ryan eds. Internal Medicine: A Guide to Clinical Therapeu+cs. McGraw- Hill 2013
16 Rivaroxaban (Xarelto ) Oral Xa inhibitor Reversible Renally cleared Must adjust Doses 15mg/day; take with food t½ ~ 10 hours DVT treatment 15mg BID X3 weeks Then 20mg QD Contraindicated <30mL/min Non- valvular afib 20mg QD CrCl 30 50mL/min 15mg QD Crcl <15mL/min Contraindicated Post- op PPX (hip/knee) 10mg QD Crcl <30mL/min Contraindicated
17 Rivaroxaban No specific an+dote Not dialyzable High protein binding Life- threatening bleed Packed RBC Aggressive bleeding management 4- factor PCC Drug interac+ons 3A4 metabolism risk of bleed An+coagulants NSAIDs An+- platelet agents Thromboly+cs 3A4 inhibitors effects Strong 3A4 inducers P- glycoprotein inducers St. Johns wort
18 Rivaroxaban Pros Once daily dosing No monitoring VTE treatment Does not require bridging with parenteral agent Cons Renally eliminated Short t½ Non- compliance issues Non- inferior to warfarin for afib More bleeding in general VTE prophylaxis popula+on Limited reversal op+ons No widely available monitoring Drug interac+ons Expensive ~$300 for 30 day supply
19 Apixaban (Eliquis ) Oral Xa inhibitor Reversible t½ ~ 8-15 hours DVT treatment 10mg BID X7 days Then 5mg BID 2.5mg BID azer 6 months Non- valvular atrial fibrilla+on 5mg BID 2.5mg BID if any 2: Scr 1.5mg/dL Age 80 Weight 60kg Post- op PPX (hip/knee) 2.5mg BID
20 Apixaban No specific an+dote Not dialyzable High protein binding Life- threatening bleed Packed RBC Aggressive bleeding management Prothrombin complex concentrate (PCC) Drug interac+ons 3A4 metabolism risk of bleed An+coagulants NSAIDs An+- platelet agents Thromboly+cs 3A4 inhibitors effects 3A4 inducers P- glycoprotein inducers St. Johns wort
21 Apixaban Pros Oral agent No monitoring No need for bridging therapy Data in afib >>> vs. warfarin Lowest compara+ve bleeding risk of NOACs Cons Dose- adjustment rubric No monitoring No specific an+dote Short t½ Non- compliance risks More GI bleeds vs. warfarin No reliable reversal agent Licle data available Cost
22 Edoxaban (Savaysa ) Oral Xa inhibitor Reversible t½ ~ 8-15 hours DVT treatment 60mg QD azer 5-10 days parenteral tx 60kg = 30mg If using P- gp inhibitor reduce to 30mg QD Renally eliminated Do NOT use if CrCl >95mL/min CrCl 15-50mL/min 30mg QD Avoid if CrCl <15mL/min
23 Edoxaban Pros Oral agent No monitoring No need for bridging therapy Cons Dose- adjustment for drug interac+ons No monitoring No specific an+dote No reliable reversal agent Licle data available Cost
25 An+coagulant Site of Ac+on Adapted from: Ryan. In Acridge, Miller, Moote, Ryan eds. Internal Medicine: A Guide to Clinical Therapeu+cs. McGraw- Hill 2013
26 Direct Thrombin Inhibitors Inhibit thrombin Circula+ng & fibrin- bound Do not need an+- thrombin as co- factor HIT No cross- reac+vity with heparin products No specific an+dote
27 Dabigatran (Pradaxa ) Oral reversible thrombin inhibitor RELY trial compared to warfarin in afib Decreased stroke risk Similar overall bleeding No superiority if good warfarin control 2X é GI bleed» Bioavailability? ê risk intracranial bleed Non- valvular atrial fibrilla+on 150mg BID Renal clearance 75mg BID ClCr 15 30mL/min Contraindicated <15mL/min DVT/PE 150mg BID Azer parenteral an+coagulant
28 Dabigatran Hygroscopic capsules Dispense/store in original packaging Discard 4 months azer opening Do not break or open capsule é bioavailability t½ ~ hours Adverse effects Bleeding GI distress No an+dote May be reversed by prothrombin complex concentrate (PCC) Provides factor II Removed by hemodialysis
29 Dabigatran Drug interac+ons P- glycoprotein inducers ê dabigatran concentra+ons Avoid combina+on with strong inducers Rifampin Elderly Increased bleeding risk; no specific dosing guidelines Disease- related concerns Variability in hepa+c impairment Use in advanced liver disease not recommended Renal dysfunc+on Concentra+on é up to 3X with moderate ê func+on American College of Chest Physicians (ACCP)*» Clcr <30mL/min contraindicated
30 Dabigatran In the News BMJ inves+ga+on States recommenda+ons for dabigatran may be flawed Manufacturers withheld informa+on showing drug concentra+on monitoring may improved safety Op+mally used (= +trated) dabigatran has the poten+al to provide pa+ents an even becer efficacy and safety profile than fixed dose dabigatran and also a becer safety and efficacy profile than a matched warfarin group. BMJ 2014;349
31 Dabigatran Pros Oral agent No monitoring More effec+ve vs. warfarin for stroke & VTE No lifestyle limita+ons Cons No monitoring* Drug interac+ons with p- glycoprotein inducers Renally eliminated No specific an+dote Increased GI bleeding Short t½ Non- compliance risks BID dosing Capsule instability Cost
33 Current Reversal Op+ons Agent Vitamin K Protamine Sulfate Fresh Frozen Plasma (FFP) Comments Cheapest agent, most data; only effec+ve against warfarin Binds to heparin; cheap Must be thawed, high volume; contains all clokng factors Prothrombin Complex Concentrates (PCC) Recombinant ac+vated factor VII *per977 *andexanet alfa (Annexa- R) *idracizumab Profilnine /Bebulin - - ac+vated factors II/IX/X $$ Kcentra /Feiba - - non- ac+vated factors II/IX/X + ac+vated fvii $$ $$$$$$$ Directly combines with NOACs, LMWH, UFH without binding coagula+on factors IV modified Xa molecule acts as a decoy; targets & sequesters Xa inhibitors (rivaroxaban, apixaban, edoxaban) IV an+body fragment binds & inac+vates dabigatran *currently in clinical trials
35 Typical Dosing Regimens Factor Xa Inhibitors Rivaroxaban (Xarelto ) Apixaban (Eliquis ) Edoxaban (Savaysa ) Dabigatran (Pradaxa ) Afib: 20mg QDay VTE: 15mg BID X 21days; then 20mg QDay DVT PPX: 10mg QDay up to 35 days post- op Afib: 5mg BID VTE: 10mg BID X 7days; 5mg BID X6 months; 2.5mg BID if con+nuing therapy DVT PPX: 2.5mg BID up to 35 days post- op Afib: 60mg QDay VTE: 60mg QDay azer 5-10 days parenteral tx Direct Thrombin Inhibitor Afib: 150mg BID VTE: 150mg BID azer 5-10 days parenteral tx
36 Conversions.to NOAC. From warfarin Start NOAC when INR < 2 Edoxaban when INR 2.5 From SQ an+coagulant Start NOAC 2 hours before the next scheduled SC injec+on At scheduled +me for edoxaban From IV an+coagulant Start NOAC when infusion is stopped 4 hours azer DC for edoxaban from NOAC to Parenteral an+coagulant Wait hours azer last NOAC dose Warfarin CrCl > 50 ml/min: Start warfarin 3 days before NOAC D/C CrCl ml/min: Start warfarin 2 days before NOAC D/C Apixaban affects INR Ini+ate warfarin AND parenteral agent 24 azer DC Edoxaban drop dose to 15mg & ini+ate warfarin; DC when INR stable 2
37 NOAC Periopera+ve Management Bleed Risk Examples Stopping strategy Re- Start Strategy High Risk Cancer surgery Major ortho surgery Cardiac/spinal/cranial surgery Surgery > 45 min Renal biopsy CrCl >50mL/min; last dose 3 days before procedure CrCl 30-50mL/min; last dose 4 days before procedure Restart 48-72h postop Low Risk Minor dental procedure Lymph node biopsy Shoulder/hand surgery Lap Cholecystectomy Colonoscopy CrCl >50mL/min; last dose 2 days before procedure CrCl 30-50mL/min; last dose 3 days before procedure Restart 24h postop
38 Oral An+coagulant Summary Drug Dosing Monitor? Dose adjust? Drug intx? Specific anhdote? Warfarin PO, daily INR, food Yes $ Cost Rivaroxaban PO, daily* No Renal No $$$ Apixaban PO, BID No Renal, wt No $$$ Edoxaban PO, daily No Renal* No $$$ Dabigatran PO, BID No Renal No* $$$
39 NOAC Summary Pros No need for bridging with injectables for some NOACs Less lifestyle intrusions compared to warfarin Less bleeding compared to warfarin? Cons $$$$ Limited reversal agents Mul+ple day dosing Limited clinical informa+on Drug interac+ons exist, but <<< vs. warfarin
40 NOAC Summary Many new an+coagulants have entered or will enter the market in the future decade A clear understanding of pros/cons of NOACs required for safe use Affordable reversal strategies s+ll needed for NOACs Warfarin s+ll viable op+on for many pa+ents, but use is decreasing
Comparative Anticoagulation
Comparative Anticoagulation Laurajo Ryan, PharmD, MSc, BCPS, CDE Clinical Associate Professor The University of Texas at Austin College of Pharmacy The University of Texas Health Science Center PharmacotherapyMore information
Speaker Disclosure. Outline. Pharmacist Objectives. Patient Case. Outline 9/4/2014
Speaker Disclosure Matthew K. Pitlick, Pharm.D., BCPS St. Louis College of Pharmacy/VA St. Louis HCS email@example.com Matthew K. Pitlick, Pharm.D., BCPS declares no conflicts of interest, real or apparent,More information
Anticoagulation and Reversal
Anticoagulation and Reversal John Howard, PharmD, BCPS Clinical Pharmacist Internal Medicine Affiliate Associate Clinical Professor South Carolina College of Pharmacy Disclosures I have no Financial, Industry,More information
Xabans Good for What Ails Ya? Brian Tiffany, MD, PhD, FACEP Dept of Emergency Medicine Chandler Regional Medical Center Mercy Gilbert Medical Center
Xabans Good for What Ails Ya? Brian Tiffany, MD, PhD, FACEP Dept of Emergency Medicine Chandler Regional Medical Center Mercy Gilbert Medical Center DISCLOSURES No relevant financial disclosures I willMore information
Objectives. New and Emerging Anticoagulants. Objectives (continued) 2/18/2014. Development of New Anticoagulants
Objectives New and Emerging Anticoagulants Adraine Lyles, PharmD, BCPS Clinical Pharmacy Specialist VCU Medical Center Describe the pharmacology of the novel oral anticoagulants Discuss the clinical evidenceMore information
The speakers have attested that their presentation will be free of all commercial bias toward a specific company and its products.
Update on New Anticoagulants (Apixaban, Dabigatran and Rivaroxaban) Patient Safety Daniel B. DiCola, MD and Paul Ament,, Pharm.D Excela Heath, Latrobe, PA Disclosures: Paul Ament discloses that he receivesMore information
DVT/PE Management with Rivaroxaban (Xarelto)
DVT/PE Management with Rivaroxaban (Xarelto) Rivaroxaban is FDA approved for the acute treatment of DVT and PE and reduction in risk of recurrence of DVT and PE. FDA approved indications: Non valvularMore information
48 th Annual Meeting. Non-VKA Oral Anticoagulants: Prevention & Treatment of Bleeding. Terminology. Disclosure. Public Health Impact.
48 th Annual Meeting Terminology Non-VKA Oral Anticoagulants: Prevention & Treatment of Bleeding Stacy A. Voils, PharmD, MS, BCPS Navigating the Oceans of Opportunity Target-specific oral anticoagulantsMore information
New Anticoagulants: What to Use What to Avoid
New Anticoagulants: What to Use What to Avoid Bruce Davidson, MD, MPH Clinical Professor of Medicine Pulmonary and Critical Care Medicine Division University of Washington School of Medicine Seattle USAMore information
3/3/2015. Patrick Cobb, MD, FACP March 2015
Patrick Cobb, MD, FACP March 2015 I, Patrick Cobb, MD, DO NOT have a financial interest/arrangement or affiliation with one or more organizations that could be perceived as a real or apparent conflictMore information
DOACs. What s in a name? or TSOACs. Blood Clot. Darra Cover, Pharm D. Clot Formation DOACs work here. Direct Oral AntiCoagulant
DOACs NOACs or TSOACs Generic Name DOACs Brand Name Mechanism of Action Direct Xa Inhibitor Direct Thrombin Inhibitor Dabigatran Pradaxa X Rivaroxaban Xarelto X Darra Cover, Pharm D Apixaban Eliquis XMore information
FDA Approved Oral Anticoagulants
FDA Approved Oral Anticoagulants Generic (Trade Name) Warfarin (Coumadin, Jantoven ) 1 FDA approved indication Prophylaxis and treatment of venous thromboembolism (VTE) Prophylaxis and treatment of thromboembolicMore information
Analyzing Clinical Trial Findings of the Efficacy and Safety Profiles of Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation
Analyzing Clinical Trial Findings of the Efficacy and Safety Profiles of Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation Drew Baldwin, MD Virginia Mason Seattle, Washington NCVH May 29,More information
The author has no disclosures
Mary Bradbury, PharmD, BCPS Clinical Pharmacy Specialist, Cardiac Surgery September 18, 2012 email@example.com This presentation will discuss unlabeled and investigational use of products The authorMore information
Comparison between New Oral Anticoagulants and Warfarin
Comparison between New Oral Anticoagulants and Warfarin Warfarin was the mainstay of oral anticoagulant therapy until the recent discovery of more precise targets for therapy. In recent years, severalMore information
Traditional anticoagulants
TEGH Family Practice Clinic Day April 4, 03 Use of Anticoagulants in 03: What s New (and What Isn t) Bill Geerts, MD, FRCPC Director, Thromboembolism Program, Sunnybrook HSC Professor of Medicine, UniversityMore information
Conserva)ve Treatment of PE/ DVT
Conserva)ve Treatment of PE/ DVT Amir Kaki, MD FACC FSCAI Asst Prof of Medicine Wayne St SOM Medical Director Cardiac Catheteriza)on Lab Heart Hospital DMC Detroit, MI Incidence Acute pulmonary embolismMore information
Critical Bleeding Reversal Protocol
Critical Bleeding Reversal Protocol Coagulopathy, either drug related or multifactorial, is a major contributing factor to bleeding related mortality in a variety of clinical settings. Standard therapyMore information
Venous Thromboembolism: Long Term Anticoagulation. Dan Johnson, Pharm.D.
Venous Thromboembolism: Long Term Anticoagulation Dan Johnson, Pharm.D. Disclosures No financial relationships with products discussed Off-label use of drug therapy always discussed Objectives Review clinicalMore information
Disclosure/Conflict of Interest
NEW ORAL ANTICOAGULANTS: WHAT EVERY PHARMACIST SHOULD KNOW LORI B. HORNSBY, PHARMD, BCPS ASSOCIATE CLINICAL PROFESSOR AUHSOP CLINICAL PHARMACIST MIDTOWN MEDICAL CENTER OUTPATIENT CLINIC COLUMBUS, GEORGIAMore information
New Anticoagulation Options for Stroke Prevention in Atrial Fibrillation. Joy Wahawisan, Pharm.D., BCPS April 25, 2012
New Anticoagulation Options for Stroke Prevention in Atrial Fibrillation Joy Wahawisan, Pharm.D., BCPS April 25, 2012 Stroke in Atrial Fibrillation % Stroke 1991;22:983. Age Range (years) CHADS 2 RiskMore information
PGY1 Pharmacy Practice St. Vincent Hospital PGY2 Ambulatory Care St. Vincent Primary Care Center
Speaker Introduction Jessica Wilhoite, PharmD, BCACP Doctor of Pharmacy: Purdue University Postgraduate Residency Training: PGY1 Pharmacy Practice St. Vincent Hospital PGY2 Ambulatory Care St. VincentMore information
5/21/2012. Perioperative Use Issues. On admission: During hospitalization:
Dabigatran and Rivaroxaban: Challenges in the Perioperative Setting Claudia Swenson, Pharm.D., CDE, BC-ADM, FASHP Central Washington Hospital Wenatchee, WA firstname.lastname@example.com Dabigatran and Rivaroxaban:More information
Management of invasive procedures and bleeding compica5ons in pa5ents on NOACs
Management of invasive procedures and bleeding compica5ons in pa5ents on NOACs Michiel Coppens MD PhD Internist- Vascular Medicine Academic Medical Center, Amsterdam, The Netherlands McMaster University,More information
Making Sense of the Newer Anticoagulants
Making Sense of the Newer Anticoagulants Brian Tiffany, MD, PhD, FACEP Dept of Emergency Medicine Chandler Regional Medical Center Mercy Gilbert Medical Center I M FROM ARIZONA! DISCLOSURES No relevantMore information
Warfarin and Novel Anti-Coagulants: Management Before and After the Cath Lab
Warfarin and Novel Anti-Coagulants: Management Before and After the Cath Lab Drew Baldwin, MD Virginia Mason Seattle, Washington NCVH May 28, 2015 2:30 pm I have no disclosures. Stroke risk reduction inMore information
Reversal of Antiplatelet and Anticoagulant Therapy: What You Need To Know. Ronald Walsh, MD Chief Medical Officer Community Blood Services
Reversal of Antiplatelet and Anticoagulant Therapy: What You Need To Know Ronald Walsh, MD Chief Medical Officer Community Blood Services HEMOSTATIC PROCESS Initiation and formation of the platelet plugMore information
Stop the Bleeding: Management of Drug-induced Coagulopathy. Stacy A. Voils, PharmD, BCPS Critical Care Specialist, Neurosurgery
Stop the Bleeding: Management of Drug-induced Coagulopathy Stacy A. Voils, PharmD, BCPS Critical Care Specialist, Neurosurgery Objectives Discuss contemporary management of warfarin reversal in patientsMore information
3/25/14. To Clot or Not What s New In Anticoagulation? Clotting Cascade. Anticoagulant drug targets. Anita Ralstin, MS CNS CNP. Heparin.
To Clot or Not What s New In Anticoagulation? Anita Ralstin, MS CNS CNP 1 Clotting Cascade 2 Anticoagulant drug targets Heparin XI VIII IX V X VII LMWH II Warfarin Fibrin clot 1 Who Needs AnticoagulationMore information
2.5mg SC daily. INR target 2-3 30 mg SC q 12 hr or 40mg daily. 10 mg PO q day (CrCl 30 ml/min). Avoid if < 30 ml/min. 2.
Anticoagulation dosing at UCDMC (SC=subcutaneously; CI=continuous infusion) Indication Agent Dose Comments Prophylaxis Any or No bleeding risk factors see adult heparin (VTE prophylaxis) IV infusion orderMore information
DABIGATRAN ETEXILATE TARGET Vitamin K epoxide reductase WARFARIN RIVAROXABAN APIXABAN
TARGET SPECIFIC ORAL ANTICOAGULANTS (TSOACs) This document is intended as a guideline only and should not replace sound clinical judgment Please refer to UNMH formulary in Lexicomp for approved use(s)More information
Anticoagulation Essentials! Parenteral and Oral!
Anticoagulation Essentials! Parenteral and Oral! Anti-Xa and Anti-IIa! Parenteral Anticoagulants! Heparin family (indirect anti-xa and anti-iia):! UFH! LMWH (enoxaparin, fondaparinux)! Direct thrombinMore information
CONTEMPORARY REVERSAL OF ANTICOAGULATION Michael S. McHale, M.D., F.A.C.P. Avera Medical Group Hematology & Oncology Medications Coumadin / Warfarin Unfractionated Heparin Low Molecular Weight HeparinMore information
Devang M. Desai, MD, FACC, FSCAI Chief of Interventional Cardiology Director of Cardiac Catheterization Lab St. Mary s Hospital and Regional Medical
Devang M. Desai, MD, FACC, FSCAI Chief of Interventional Cardiology Director of Cardiac Catheterization Lab St. Mary s Hospital and Regional Medical Center A.Fib affects 2.2 million Americans. The lifetimeMore information
Clinical Assistant Professor University of Kansas School of Pharmacy. Objectives
New Oral Anticoagulants Tiffany R. Shin, PharmD, BCACP Clinical Assistant Professor University of Kansas School of Pharmacy 1 Objectives Discuss the advantages and disadvantages of the new oral anticoagulantsMore information
Failure or significant adverse effects to all of the alternatives: Eliquis and Xarelto
This policy has been developed through review of medical literature, consideration of medical necessity, generally accepted medical practice standards, and approved by the IEHP Pharmacy and TherapeuticsMore information
Disclosure. New Agents for Treatment of DVT. Prevalence of DVT VTE. Normal Hemostasis 7/17/2015. Mark Oliver, MD, RVT, RPVI,FSVU
New Agents for Treatment of DVT Disclosure PI Adopt and Amplify trials Mark Oliver, MD, RVT, RPVI,FSVU BMS and Pfizer Speaker VTE Venous Thromboembolism Recognized DVT s New : 170,000 Recurrent : 90,000More information
Anticoagulation Dosing at UCDMC Indication Agent Standard Dose Comments and Dose Adjustments VTE Prophylaxis All Services UFH 5,000 units SC q 8 h
Indication Agent Standard Dose Comments and Dose Adjustments VTE Prophylaxis All Services UFH 5,000 units SC q 8 h See EMR adult VTE prophylaxis CI order set Enoxaparin See service specific dosing AssessMore information
New Oral Anticoagulants
Disclosures The New Oral Anticoagulants: Are they better than Warfarin? Alan P. Agins, Ph.D. does not have any actual or potential conflicts of interest in relation to this CE activity. Alan Agins, Ph.D.More information
Disclosures. Objective (NRHS) Self Assessment #2
Development and Implementation of a Protocol for Reversing the Effects of Anticoagulants for Use in a Community Hospital Samantha Sepulveda, Pharm.D. PGY1 Pharmacy Resident Norman Regional Health SystemMore information
New Oral Anticoagulants
New Oral Anticoagulants Tracy Minichiello, MD Associate Professor of Medicine Chief, San FranciscoVA Anticoagulation and Thrombosis Service Ansell, J. Hematology Copyright 2010 American Society of Hematology.More information
Disclosures. New Developments in Oral Anticoagulants: Treating and Preventing Embolic Events in the 21 st Century
New Developments in Oral Anticoagulants: Treating and Preventing Embolic Events in the 21 st Century David Stewart, PharmD, BCPS Associate Professor of Pharmacy Practice East Tennessee State UniversityMore information
TSOAC Initiation Checklist
Task Establish appropriate dose based on anticoagulant selected, indication and patient factors such as renal function. Evaluate for medication interactions that may necessitate TSOAC dose adjustment.More information
The Brave New (Anticoagulant) World
The Brave New (Anticoagulant) World Diane M. Birnbaumer, M.D., FACEP Emeritus Professor of Medicine University of California, Los Angeles Senior Clinical Educator Department of Emergency Medicine Harbor-UCLAMore information
Update on Antiplatelets and anticoagulants. Outlines. Antiplatelets and Anticoagulants 1/23/2013. Timir Paul, MD, PhD
Update on Antiplatelets and anticoagulants Timir Paul, MD, PhD Antiplatelets Indications Doses Long term use (beyond 12 months) ASA and combination use of NSAIDS ASA resistance Plavix resistance PlavixMore information
The Role of the Newer Anticoagulants
The Role of the Newer Anticoagulants WARFARIN = Coumadin DAGIBATRAN = Pradaxa RIVAROXABAN = Xarelto APIXABAN = Eliquis INDICATION DABIGATRAN (Pradaxa) RIVAROXABAN (Xarelto) APIXABAN (Eliquis) Stroke preventionMore information
Management for Deep Vein Thrombosis and New Agents
Management for Deep Vein Thrombosis and New Agents Mark Malesker, Pharm.D., FCCP, FCCP, FASHP, BCPS Professor of Pharmacy Practice and Medicine Creighton University 5 th Annual Creighton CardiovascularMore information
Reversing the New Anticoagulants
Reversing the New Anticoagulants Disclosure Susan C. Lambe, MD Assistant Clinical Professor Department of Emergency Medicine University of California, San Francisco Roadmap for today 1 Roadmap for todayMore information
A PRACTICAL REVIEW OF THE NOVEL ORAL ANTICOAGULANTS BRIAN CRYDER, PHARMD BCACP LEARNING OBJECTIVES AS A RESULT OF THIS PRESENTATION, THE AUDIENCE WILL BE ABLE TO 1. DISCUSS THE KEY DIFFERENCES BETWEENMore information
New Oral Anticoagulants. July 2012
New Oral Anticoagulants July 2012 Objectives Review coagulation cascade and previous treatment options for anticoagulation Understand points of interaction within coagulation cascade and new oral agentsMore information
New Oral Anticoagulants. How safe are they outside the trials?
New Oral Anticoagulants How safe are they outside the trials? Objectives The need for anticoagulant therapy Indications for anticoagulation Traditional anticoagulant therapies Properties of new oral anticoagulantsMore information
New Anticoagulation Agents and Their Reversal Agents. Objectives. Background 12/21/2015
New Anticoagulation Agents and Their Reversal Agents Jay Hazelcorn, Pharm.D. PGY-1 Pharmacy Resident Broward Health Medical Center Objectives Review the pharmacology, indications, and place in therapyMore information
NnEeWw DdEeVvEeLlOoPpMmEeNnTtSs IiıNn OoRrAaLl AaNnTtIiıCcOoAaGgUuLlAaTtIiıOoNn AaNnDd RrEeVvEeRrSsAaLl
NnEeWw DdEeVvEeLlOoPpMmEeNnTtSs IiıNn OoRrAaLl AaNnTtIiıCcOoAaGgUuLlAaTtIiıOoNn AaNnDd RrEeVvEeRrSsAaLl Mikele Wissing, RN June 2014 Introduction until recently, was the unrivaled medication for treatmentMore information
Novel oral anticoagulant (NOAC) for stroke prevention in atrial fibrillation Special situations
Novel oral anticoagulant (NOAC) for stroke prevention in atrial fibrillation Special situations Dardo E. Ferrara MD Cardiac Electrophysiology North Cascade Cardiology PeaceHealth Medical Group Which anticoagulantMore information
New Anticoagulants: When and Why Should I Use Them? Disclosures
Winship Cancer Institute of Emory University New Anticoagulants: When and Why Should I Use Them? Christine L. Kempton, MD, MSc Associate Professor of Pediatrics and Hematology and Medical Oncology HemophiliaMore information
The New An)coagulants: Prac)cal Applica)on. Ma8hew Rondina, M.D. Department of Internal Medicine University of Utah Medical Center
The New An)coagulants: Prac)cal Applica)on Ma8hew Rondina, M.D. Department of Internal Medicine University of Utah Medical Center Learning Objec)ves 1. Understand the prac)cal considera)ons and poten)alMore information
The New Oral Anticoagulants: When and When Not to Use Them Philip C. Comp, M.D., Ph.D. Professor of Medicine, University of Oklahoma Health Sciences
The New Oral Anticoagulants: When and When Not to Use Them Philip C. Comp, M.D., Ph.D. Professor of Medicine, University of Oklahoma Health Sciences Center September 25, 2015 Question: With which of theMore information
Oral Anticoagulants: What s New?
Oral Anticoagulants: What s New? Sallie Young, Pharm.D., BCPS (AQ-Cardiology) Clinical Pharmacy Specialist, Cardiology Penn State Hershey Medical Center email@example.com August 2012 Oral AnticoagulantMore information
Anticoagulation in Atrial Fibrillation
Anticoagulation in Atrial Fibrillation Parag P. Patel, MD FACC Disclosures Eliquis Speakers Bureau 1 Clinical Scenario Ms. L is a 76F admitted to the stroke service with a dense right sided hemiparesisMore information
Cardiology Update 2014
Cardiology Update 2014 Update on the Novel Oral Anticoagulants (NOACS) Raymond Kawasaki, MD AMG Cardiology December 6, 2014 Disclosures I have no disclosures relevant to this presentation Contents I. TheMore information
Dabigatran (Pradaxa) Guidelines
Dabigatran (Pradaxa) Guidelines Dabigatran is a new anticoagulant for reducing the risk of stroke in patients with atrial fibrillation. Dabigatran is a direct thrombin inhibitor, similar to warfarin, withoutMore information
Guideline for the Prescribing of Novel Oral Anticoagulants (NOACs): Dabigatran (Pradaxa ), Rivaroxaban (Xarelto ), Apixaban (Eliquis )
Guideline for the Prescribing of Novel Oral Anticoagulants (NOACs): Dabigatran (Pradaxa ), Rivaroxaban (Xarelto ), Apixaban (Eliquis ) The contents of this CPG are to be used as a guide. Healthcare professionalsMore information
LAMC Reversal Agent Guideline for Anticoagulants 2013. Time to resolution of hemostasis (hrs) Therapeutic Options
LAMC Reversal Agent Guideline for Anticoagulants 2013 Medication resolution of hemostasis (hrs) Intervention Administration Instructions Heparin 3-4 Protamine 1mg IV for every 100 units of heparin SlowMore information
Antiplatelet and Antithrombotic Therapy. Dr Curry Grant Stroke Prevention Clinic Quinte Health Care
Antiplatelet and Antithrombotic Therapy Dr Curry Grant Stroke Prevention Clinic Quinte Health Care Disclosure of Potential for Conflict of Interest Dr. F.C. Grant Atrial Fibrillation FINANCIAL DISCLOSURE:More information
Time of Offset of Action The Trial
New Antithrombotic Agents DISCLOSURE Relevant Financial Relationship(s) Speaker Bureau - None Consultant Amgen Tom DeLoughery, MD FACP FAWM Oregon Health and Sciences University What I am Talking AboutMore information
Rivaroxaban (Xarelto ) by
Essentia Health Med Moment Short Video Tune-Up A brief overview of a new medication, or important new medication information Rivaroxaban (Xarelto ) by Richard Mullvain RPH BCPS (AQC) Current - August 2011More information
Novel Anticoagulation Agents DISCLOSURES. Objectives ATRIAL FIBRILLATION TRIALS. NOAC Comparison 6/12/2015
Novel Anticoagulation Agents DISCLOSURES James W. Haynes, MD Department of Family Medicine Univ of TN Health Science Center (Chattanooga) Objectives Understand mechanism of action behind the NOAC agentsMore information
Cardiovascular Disease
Cardiovascular Disease 1 Cardiovascular Disease 1. More target specific oral anticoagulants (TSOAC) 2. Vorapaxar (Zonivity) 3. Continued noise about a polypill 4. WATCHMAN 3 1 2 3 4 Left Atrial AppendageMore information
Session 3 Topics. Argatroban. Argatroban. Drug Use and Adverse Effects. Laboratory Monitoring of Anticoagulant Therapy
~~Marshfield Labs Presents~~ Laboratory Monitoring of Anticoagulant Therapy Session 3 of 4 Michael J. Sanfelippo, M.S. Technical Director, Coagulation Services Session 3 Topics Direct Thrombin Inhibitors:More information
Thrombosis and Hemostasis
Thrombosis and Hemostasis Wendy Lim, MD, MSc, FRCPC Associate Professor, Department of Medicine McMaster University, Hamilton, ON Overview To review the important developments in venous thromboembolismMore information
1/7/2012. Objectives. Epidemiology of Atrial Fibrillation(AF) Stroke in AF. Stroke Risk Stratification in AF
Objectives Atrial Fibrillation and Prevention of Thrombotic Complications: Therapeutic Update Andrea C. Flores Pharm.D Pharmacy Resident at the Miami VA Healthcare System Review the epidemiology, pathophysiologyMore information
Advanced Issues in Peri-Operative VTE Prevention
Advanced Issues in Peri-Operative VTE Prevention Michael-Anthony (M-A) Williams, M.D. Consultant Physician Centura Medical Consultants September 27th, 2012 Main Topics 1. The perils of the early mover-More information
NEWER ANTICOAGULANTS: FOCUS ON STROKE PREVENTION IN ATRIAL FIBRILLATION AND DEEP VEIN THROMBOSIS/PULMONARY EMBOLISM Carol Lee, Pharm.D., Jessica C. Song, M.A., Pharm.D. INTRODUCTION For many years, warfarinMore information
Blood products and pharmaceutical emergencies
Blood products and pharmaceutical emergencies Kasey L. Bucher PharmD, BCPS Clinical Specialist, Emergency Medicine Mercy Health Saint Mary s September 12, 2013 Disclosures None significancemagazine.comMore information
Novel Oral Anticoagulants (NOACs) Prescriber Update 2013
Novel Oral Anticoagulants (NOACs) Prescriber Update 2013 Indications/Contraindications Indications Orthopedic VTE Prophylaxis VTE Treatment Stroke Prevention for non-valvular AF Contraindications 150 mgMore information
MCHENRY WESTERN LAKE COUNTY EMS SYSTEM OPTIONAL CE ADVANCED LEVEL (EMTP, PHRN, ECRN) August 2013. Anticoagulants
MCHENRY WESTERN LAKE COUNTY EMS SYSTEM OPTIONAL CE ADVANCED LEVEL (EMTP, PHRN, ECRN) August 2013 Anticoagulants Anticoagulants are agents that prevent the formation of blood clots. Before we can talk aboutMore information
Current and Emerging Therapies for Perioperative Anticoagulation Reversal
Current and Emerging Therapies for Perioperative Anticoagulation Reversal Eric Johnson, PharmD, BCCCP Critical Care Pharmacist- Perioperative Services Objectives Detail the approach to perioperative anticoagulationMore information
Efficacy in Hip Arthroplasty. Efficacy in Knee Arthroplasty. Adverse Effects. Drug Interactions
Objectives Just for the RECORD: Rivaroxaban joins the US Anticoagulation Arsenal Anne P. Spencer, PharmD, FCCP, BCPS (AQ Cardiology) Cardiovascular Care Pharmacy Specialist Roper Saint Francis HealthcareMore information
Non- Valvular Atrial Fibrillation and Stroke Prevention: Which OAC Do I Choose. Warfarin vs the NOACs
Non- Valvular Atrial Fibrillation and Stroke Prevention: Which OAC Do I Choose Warfarin vs the NOACs Dr. Lori McIntosh D.O. Board Certified Neurologist Objectives Be able to list the current options ofMore information
New Oral Anticoagulants (NOACs)
New Oral Anticoagulants (NOACs) Dabigatran (Pradaxa) Rivaroxaban (Xarelto) Apixaban (Eliquis) Edoxaban (Savaysa) Janice Lawson, MD Tallahassee Memorial Hospital Cancer and Hematology Specialists DisclosureMore information
Timeline: FDA approval of NOACs. FDA-approved oral anticoagulants. FDA-approved oral anticoagulants. Stroke risk reductions: afib RCTs 4/8/2016
Christina York, PharmD, BCPS Pharmacology Conference April 2016 Objectives Compare current FDA-approved oral anticoagulants Understand practical issues that arise with novel oral anticoagulants ConsiderMore information
Program Objectives. Why Use Anticoagulants? 6/5/2014
Larry Reis RPh CGP FASCP Prepared June 2014 for NADONA REIS RXCARE CONSULTING email@example.com 1 Program Objectives Discuss complications of current anticoagulant Rx Identify risks of using anticoagulantsMore information
Disclosure. Warfarin
Disclosure No conflicts of interest to disclose Reversal Strategies for Novel Oral Anticoagulants Noelle de Leon, PharmD, BCPS Critical Care Pharmacist, Department of Pharmaceutical Services AssistantMore information
Laboratory Testing in Patients on Novel Oral Anticoagulants (NOACs)
Laboratory Testing in Patients on Novel Oral Anticoagulants (NOACs) Dr. Art Szkotak firstname.lastname@example.com University of Alberta Hospital Edmonton, AB NOACs Direct Thrombin Inhibitors (DTI):More information
OMG my pa*ent is bleeding pa*ent is on NOACs!! Bryan Poon, PharmD Clinical Quality Manager UT Southwestern Medical Center at Dallas
OMG my pa*ent is bleeding pa*ent is on NOACs!! Bryan Poon, PharmD Clinical Quality Manager UT Southwestern Medical Center at Dallas Disclosure Financial disclosure: NONE Off label drug use disclosure:More information
Reversal of Anticoagulants at UCDMC
Reversal of Anticoagulants at UCDMC Introduction: Bleeding complications are a common concern with the use of anticoagulant agents. In selected situations, reversing or neutralizing the effects of an anticoagulantMore information
How to Manage Warfarin Management
How to Manage Warfarin Management Katie McClendon, PharmD, BCPS University of Mississippi School of Pharmacy AS MANDATED BY ACCME SPEAKERS ARE ASKED TO DISCLOSE ANY REAL OR APPARENT CONFLICT RELATED TOMore information
Optimizing Anticoagulation Selection for Your Patient. C. Andrew Brian MD, FACC NCVH 2015
Optimizing Anticoagulation Selection for Your Patient C. Andrew Brian MD, FACC NCVH 2015 Who Needs to Be Anticoagulated and What is the Patient s Risk? 1. Atrial Fibrillation ( nonvalvular ) 2. What regimenMore information
ANTICOAGULATION UPDATE C AR R I E P AL M E R, D N P, RN, AN P - BC OBJECTIVES At the end of the presentation, the NP will be able to: Identify new indications for target-specific oral anticoagulants (TSOACs),More information
Home treatment of VTE
Home treatment of VTE Prof. Adel El-Etriby Ain-Shams University Venous Thromboembolism (VTE): The DVT and PE Continuum Migration Embolus Thrombus VTE refers to a continuum of disease that begins with DVTMore information
indications November 2 nd, 2012 Dalhousie University
+ New oral anticoagulants: A review of current indications November 2 nd, 2012 Dr. Sudeep Shivakumar, Hematology Dalhousie University + Objectives es To review indications for anticoagulation To discussMore information
It s a. of Anticoagulation. Objectives
It s a New World of Anticoagulation LAURA B. RICHARDSON, PHARMD, BCPS-CV CLINICAL PHARMACIST ABBOTT NORTHWESTERN HOSPITAL Objectives Understand the key differences between the oral anticoagulants t BecomeMore information
An#coagulant Choices in Renal Impairment
An#coagulant Choices in Renal Impairment Karen Shalansky, Pharm.D. Pharmacotherapeu#c Specialist, Nephrology Vancouver General Hospital Clinical Professor Faculty of Pharmaceu#cal Sciences, UBC email@example.com information
ISSUE DATE June 22, 2015 SUBJECT EFFECTIVE DATE MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Prior Authorization of Anticoagulants Pharmacy Service Leesa M. Allen, Deputy Secretary Office of MedicalMore information
Goals 6/6/2014. Stroke Prevention in Atrial Fibrillation: New Oral Anti-Coagulants No More INRs. Ashkan Babaie, MD
Stroke Prevention in Atrial Fibrillation: New Oral Anti-Coagulants No More INRs Ashkan Babaie, MD Arrhythmia Service Providence Heart Clinic June 8 th, 2014 Goals Discuss the data behind approval of NOACsMore information
Low Molecular Weight Heparin. All Wales Medicines Strategy Group (AWMSG) Recommendations and advice
Low Molecular Weight Heparin All Wales Medicines Strategy Group (AWMSG) Recommendations and advice Starting Point Low Molecular Weight Heparin (LMWH): Inhibits factor Xa and factor IIa (thrombin) SmallMore information
Traveller s Thrombosis. Dr. Peter Verhamme Vascular Medicine and Haemostasis UZ Leuven
Traveller s Thrombosis Dr. Peter Verhamme Vascular Medicine and Haemostasis UZ Leuven Case 1: To thromboprophylaxe or not Women, aged 49, BMI 29, Combined Oral Contraceptives. Family history of provokedMore information
Novel OAC s : How should we use them?
Novel OAC s : How should we use them? Jean C. Grégoire MD, FRCP(c), FACC, FACP Associate Professor, Université de Montréal, IntervenJonal Cardiologist, InsJtut de cardiologie de Montréal Disclosures SpeakerMore information
EMMC Guide on Management of Anticoagulant and Anti-Platelet Agent Associated Bleeding Complications in Adults. February, 2013
EMMC Guide on Management of Anticoagulant and Anti-Platelet Agent Associated Bleeding Complications in Adults February, 2013 1 Quick Index To Reversal Recommendations Anti-Platelet Medications Page P2Y12More information
New Anticoagulants for the Treatment of Thromboembolism With a little subplot on superficial thrombophlebitis. Mark Crowther
New Anticoagulants for the Treatment of Thromboembolism With a little subplot on superficial thrombophlebitis Mark Crowther 1 Disclosures Advisory Boards in last 24 months Pfizer, Alexion, Bayer, CSL Behring,More information


text:
More than 8,000 people in Turkish military, police and other public institutions have been dismissed over their suspected links with the Fetullah Terrorist Organization (FETO), private broadcaster CNN Turk reported Saturday (Jan. 7).
Under three statutory decrees issued late Friday, 1,699 personnel were discharged in the Ministry of Justice, including eight members of the Council of State and one from the Supreme Electoral Council.
A total of 2,687 police officers including 53 high-ranked commissioners and 919 chief officers were removed from the Security General Directorate.
763 officers were dismissed, thus bringing the total number of people dismissed from the Turkish Armed Forces to 6,517, CNN Turk reported.
Some 786 people were dismissed from universities across the country, of which 631 were academicians and 155 were administrative staff.
Additionally, 838 in the Ministry of Heath have been also discharged. And 83 associations and foundations were shut down.
Meanwhile, 276 people, who had been formerly dismissed with previous statutory decrees, were reinstated to their jobs. And 11 newspapers which were closed as part of terror probes have been reopened.
According to the new law, Turkish citizens abroad who do not respond to judicial summons issued by courts or prosecutors within 90 days might face losing their citizenship.
The statutory decrees also said that police have been authorized to access identity information of internet subscribers for the purposes of investigating crimes committed online.
The new decrees were published as part of the state of emergency Turkey declared after the failed coup attempt in July last year.
A book entitled Japanese Militarism and Its War Crimes in Asia Pacific Region (Hendrajit, ed) was recently sent to me, by the publisher, The Global Future Institute. No doubt, this book made me re-think and recollect my trip to Japan in 1996. At that time, I was warmly received by Japanese families who became my host, invited to travel to various places, and bought souvenirs. The psycological effect of my short visit is that it is hard to imagine that the Japanese people were cruel ones, perpetrators of the massacre of our ancestors, raping Indonesian girls, making them as prostitutes and enslaving our grandfathers to work on various projects.


text:
Draconian defense budget cuts of at least $450 billion—and possibly as much as $1.2 trillion under sequestration—are casting doubt on the U.S. commitment to peace and security in the Asia–Pacific. Japan's inability to come to agreement with its principle ally complicates this already disconcerting picture. It only increases insecurity in a region groping for ways to cope with a rapidly modernizing Chinese military, an unstable North Korea, and other security threats, according to Heritage expert Bruce Klingner.
Read Full Article »